Under construction – not a live service
Sign in
Taking people in United KingdomNo phase

Tests vitamin B6 supplement for sensory reactivity in autistic adults

Compares high-dose vitamin B6 with a placebo in autistic adults with sensory differences.

Plain-language title generated from the registry record
Registry title: Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism

Key facts

Where
Reading, United KingdomSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

Source: NCT06234501, who can take part

Where in United Kingdom

  • University of ReadingReading, United KingdomTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Reading
Trial code
NCT06234501
Record updated
7 October 2026
Original description
This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.Read full original descriptionShow less

Testing the Potential of High-dose Vitamin B6 Supplements for Sensory Reactivity in Autism

This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.

Inclusion: Between the ages of 18 to 60; With a diagnosis of autism.

Exclusion: Taking any supplement that contains more than 2mg of Vitamin B6 or taking GABA agonist drugs; Have a medical history of peripheral neuropathy; lactose intolerance (placebo tablet is lactose based).

ClinicalTrials.gov NCT06234501